Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam D Devore

Showing results (331-340 of 339) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 339 results.
JAMA|July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical TrialAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 28, 2026
Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (CMV D+R-) solid organ transplant recipients with prolonged follow-up: a ten-year experienceMadeleine R Heldman, Eileen K Maziarz, Jennifer L Saullo, et al.
JACC. Heart Failure|January 26, 2024
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND TrialJacob N Schroder, Chetan B Patel, Adam D DeVore, et al.
JACC. Heart Failure|June 5, 2026
Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT StudyPalak Shah, Paul J Kim, Kelly H Schlendorf, et al.
JACC. Heart Failure|October 11, 2025
Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart TransplantationLauren K Truby, Yasbanoo Moayedi, Marisa Signorile, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.
The New England Journal of Medicine|June 7, 2023
Transplantation Outcomes with Donor Hearts after Circulatory DeathJacob N Schroder, Chetan B Patel, Adam D DeVore, et al.
Pageof 34

Showing results (331-340 of 339) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 339 results.
JAMA|July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical TrialAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 28, 2026
Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (CMV D+R-) solid organ transplant recipients with prolonged follow-up: a ten-year experienceMadeleine R Heldman, Eileen K Maziarz, Jennifer L Saullo, et al.
JACC. Heart Failure|January 26, 2024
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND TrialJacob N Schroder, Chetan B Patel, Adam D DeVore, et al.
JACC. Heart Failure|June 5, 2026
Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT StudyPalak Shah, Paul J Kim, Kelly H Schlendorf, et al.
JACC. Heart Failure|October 11, 2025
Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart TransplantationLauren K Truby, Yasbanoo Moayedi, Marisa Signorile, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.
The New England Journal of Medicine|June 7, 2023
Transplantation Outcomes with Donor Hearts after Circulatory DeathJacob N Schroder, Chetan B Patel, Adam D DeVore, et al.
Pageof 34